Role of the estrogen antagonist ICI 182,780 in vessel assembly and apoptosis of endothelial cells

Ultrastructural Pathology

Volumn 27, Issue 1, 2003, Pages 33-39

  Soares, Raquel ^a,b   Guo, Shanchun ^c   Russo, Jose ^c   Schmitt, Fernando ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c FOX CHASE CANCER CENTER   (United States)

^d University of Porto   (Portugal)

Author keywords

17 estradiol; Angiogenesis; Antiestrogens; cDNA array; HUVEC; ICI 182,780

Indexed keywords

ANTIESTROGEN; COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; MATRIGEL;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR CELL; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; CAPILLARIES; CASPASES; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN ANTAGONISTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037220125     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.1080/01913120309946     Document Type: Article

References (20)

1. Folkman J. Clinical application of research on angiogenesis. N Engl J Med. 1995;333:1757-1763.
2. Marinho A, Soares R, Ferro J, Lacerda M, Schmitt FC. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract. 1997;193:267-273.
3. Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nature. 2000;407:249-257.
4. Mendelsohn ME, Karas RH. Mechanisms of disease: the protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
5. Hyder S, Nawaz Z, Chiappetta C, Stancel G, Identification of functional estrogen response elements in the gene coding for the potent vascular endothelial growth factor. Cancer Res. 2000;60:3183-3190.
6. Gustafsson JA. Estrogen receptor β - a new dimension in estrogen mechanisms of action. J Endocrinol. 1999;163:379-383.
7. Lee ES, Schafer J, Yao K, et al. Cross resistance of Triphenlethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice. Clin Cancer Res. 2000;6:4893-4899.
8. Wijayaratne A, Nagel S, Paige L, et al. Comparative analyses of mechanistic differences among antiestrogens. Endocrinology, 1999;140:5828-5840.
9. Hall J, Couse J, Kourach K. The multifaceted mechanisms of estrogens and estrogen receptors. J Biol Chem. 2001;276:36869-36872.
10. Dickinson R, Stancel G. Estrogen receptor-mediated processes in normal and in cancer cells. J Natl Cancer Inst Monogr. 1999;27:135-145.
11. McNamara DA, Harmey J, Wang JH, Kay E, Walsh TN, Bouchier-Hayes DJ. Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo. Eur J Surg Oncol. 2001;27:714-718.
12. Dutertre M, Smith C. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp. Ther. 2000;295:431-437.
13. Patriotis PC, Querec TD, Gruver B, Brown T, Patriotis C. ArrayExplorer, a program in visual basic for robust and accurate filter cDNA array analysis. Biotechniques. 2001;31:862-872.
14. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of the human endothelial cells into capillary-like structures. J Cell Biol. 1998;107:1589-1598.
15. Blomgren K, Zhu C, Wang X, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia. J Biol Chem. 2001;276:10191-10198.
16. Eastman A, Rigas JR. Modulation of apoptosis signaling pathways and cell cycle regulation. Semin Oncol. 1999;26:7-16.
17. Spyridopoulos I, Sullivan AB, Kearney M, Isner JM, Losordo DW. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: estradiol as a survivor factor. Circulation. 1997;18:1505-1514.
18. 2+ mobilization. Circ Res. 1997;81:885-892.
19. Venkov CD, Rankin A, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells. Circulation. 1996;94:727-733.
20. Monroe DG, Berger RR, Sanders MM. Tissue-protective effects of estrogen involve regulation of caspase gene expression. Mol Endocrinol. 2002;16:1322-1331.